Elanco Animal Health to Highlight Innovations in Upcoming Investor Conferences

Elanco Animal Health to Participate in Upcoming Investor Conferences

Elanco Animal Health Incorporated, listed on the NYSE as ELAN, has officially announced its engagement in several significant investor conferences that aim to promote its innovative contributions in the field of animal health. This series of participations is set to take place over the next few weeks, where key executives from the company will share insights and developments related to their ongoing projects and future plans.

Conference Details

The first event is scheduled for Thursday, February 27, 2025, featuring Todd Young, the executive vice president and CFO of Elanco, who will participate in a fireside chat during the Bank of America 2025 Animal Health Summit starting at 12:30 p.m. ET. Following this, on Monday, March 3, Jeff Simmons, the president and CEO, will also partake in a fireside chat at the TD Cowen 45th Annual Health Care Conference at 3:10 p.m. ET.

Additionally, Todd Young will once again represent Elanco on Tuesday, March 11, during the Barclays 27th Annual Global Healthcare Conference, which will commence at 9:00 a.m. ET. For those unable to attend the live sessions, Elanco offers webcasts of these events accessible through the 'Events and Presentations' section of their investor website, along with later replays for a limited period.

About Elanco

Elanco Animal Health has established itself as a global pioneer in advancing animal health solutions, dedicated to both the welfare of farm animals and pets. With nearly seven decades of experience, the organization focuses on innovation to develop products and services that aid in preventing and treating diseases among animals. Elanco's mission is to add value not only to farmers and pet owners but also to veterinarians and the broader society by enhancing animal health.

The company operates on the vision of „Food and Companionship Enriching Life“—a statement that underscores its commitment to improving human-animal relationships and promoting the health of animals, humans, and our planet. Elanco emphasizes its dedication to creating tangible benefits resulting from its healthy purpose that drives initiatives aimed at social responsibility and community engagement.

For those interested in further information regarding Elanco’s offerings and mission, comprehensive details are available at www.elanco.com.

Contact Information

For investor inquiries, Tiffany Kanaga can be reached at (765) 740-0314, while media inquiries can be directed to Colleen Parr Dekker at (317) 989-7011.

In conclusion, Elanco’s participation in these conferences reflects its ongoing commitment to transparency and innovation in the animal health sector, enhancing the discourse within the investment community and setting the stage for future advancements in animal care.